These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
271 related items for PubMed ID: 18543343
1. Clinical and prognostic features of plasmacytomas: a multicenter study of Turkish Oncology Group-Sarcoma Working Party. Kilciksiz S, Celik OK, Pak Y, Demiral AN, Pehlivan M, Orhan O, Tokatli F, Agaoglu F, Zincircioglu B, Atasoy BM, Ozseker N, Yersal O, Niang U, Haydaroglu A, Turkish Oncology Group-Sarcoma Working Party. Am J Hematol; 2008 Sep; 83(9):702-7. PubMed ID: 18543343 [Abstract] [Full Text] [Related]
2. Outcomes and patterns of failure in solitary plasmacytoma: a multicenter Rare Cancer Network study of 258 patients. Ozsahin M, Tsang RW, Poortmans P, Belkacémi Y, Bolla M, Dinçbas FO, Landmann C, Castelain B, Buijsen J, Curschmann J, Kadish SP, Kowalczyk A, Anacak Y, Hammer J, Nguyen TD, Studer G, Cooper R, Sengöz M, Scandolaro L, Zouhair A. Int J Radiat Oncol Biol Phys; 2006 Jan 01; 64(1):210-7. PubMed ID: 16229966 [Abstract] [Full Text] [Related]
3. Radiotherapy in the management of solitary extramedullary plasmacytoma. Chao MW, Gibbs P, Wirth A, Quong G, Guiney MJ, Liew KH. Intern Med J; 2005 Apr 01; 35(4):211-5. PubMed ID: 15836498 [Abstract] [Full Text] [Related]
7. Radiotherapy of solitary plasmacytoma. Krause S, Hillengass J, Goldschmidt H, Debus J, Neuhof D. Ann Hematol; 2011 Sep 01; 90(9):1093-7. PubMed ID: 21336625 [Abstract] [Full Text] [Related]
8. Improved outcome in solitary bone plasmacytomata with combined therapy. Avilés A, Huerta-Guzmán J, Delgado S, Fernández A, Díaz-Maqueo JC. Hematol Oncol; 1996 Sep 01; 14(3):111-7. PubMed ID: 9119355 [Abstract] [Full Text] [Related]
9. Radiotherapy for extramedullary plasmacytoma of the head and neck. Creach KM, Foote RL, Neben-Wittich MA, Kyle RA. Int J Radiat Oncol Biol Phys; 2009 Mar 01; 73(3):789-94. PubMed ID: 18707826 [Abstract] [Full Text] [Related]
10. Radiotherapy for solitary plasmacytoma of bone and soft tissue: outcomes and prognostic factors. Suh YG, Suh CO, Kim JS, Kim SJ, Pyun HO, Cho J. Ann Hematol; 2012 Nov 01; 91(11):1785-93. PubMed ID: 22752147 [Abstract] [Full Text] [Related]
11. Prognostic factors in solitary plasmacytoma of the bone: a multicenter Rare Cancer Network study. Knobel D, Zouhair A, Tsang RW, Poortmans P, Belkacémi Y, Bolla M, Oner FD, Landmann C, Castelain B, Ozsahin M, Rare Cancer Network. BMC Cancer; 2006 May 05; 6():118. PubMed ID: 16677383 [Abstract] [Full Text] [Related]
12. Clinical features, outcome, and prognostic factors for survival and evolution to multiple myeloma of solitary plasmacytomas: a report of the Greek myeloma study group in 97 patients. Katodritou E, Terpos E, Symeonidis AS, Pouli A, Kelaidi C, Kyrtsonis MC, Kotsopoulou M, Delimpasi S, Christoforidou A, Giannakoulas N, Viniou NA, Stefanoudaki E, Hadjiaggelidou C, Christoulas D, Verrou E, Gastari V, Papadaki S, Polychronidou G, Papadopoulou A, Giannopoulou E, Kastritis E, Kouraklis A, Konstantinidou P, Anagnostopoulos A, Zervas K, Dimopoulos MA. Am J Hematol; 2014 Aug 05; 89(8):803-8. PubMed ID: 24757085 [Abstract] [Full Text] [Related]
13. Primary spinal epidural lymphoma: patients' profile, outcome, and prognostic factors: a multicenter Rare Cancer Network study. Monnard V, Sun A, Epelbaum R, Poortmans P, Miller RC, Verschueren T, Scandolaro L, Villa S, Majno SB, Ostermann S, Ozsahin M, Mirimanoff RO. Int J Radiat Oncol Biol Phys; 2006 Jul 01; 65(3):817-23. PubMed ID: 16542791 [Abstract] [Full Text] [Related]
14. Dose response and local control using radiotherapy in non-metastatic Ewing sarcoma. Paulino AC, Nguyen TX, Mai WY, Teh BS, Wen BC. Pediatr Blood Cancer; 2007 Aug 01; 49(2):145-8. PubMed ID: 16732580 [Abstract] [Full Text] [Related]
15. Total and single doses influence the effectiveness of radiotherapy in palliative treatment of plasmacytoma. Stölting T, Knauerhase H, Klautke G, Kundt G, Fietkau R. Strahlenther Onkol; 2008 Sep 01; 184(9):465-72. PubMed ID: 19016025 [Abstract] [Full Text] [Related]
16. Radiotherapy Alone is Associated with Improved Outcomes Over Surgery in the Management of Solitary Plasmacytoma. Li QW, Niu SQ, Wang HY, Wen G, Li YY, Xia YF, Zhang YJ. Asian Pac J Cancer Prev; 2015 Sep 01; 16(9):3741-5. PubMed ID: 25987031 [Abstract] [Full Text] [Related]
17. Pattern of care and impact of prognostic factors on the outcome of head and neck extramedullary plasmacytoma: a systematic review and individual patient data analysis of 315 cases. Venkatesulu B, Mallick S, Giridhar P, Upadhyay AD, Rath GK. Eur Arch Otorhinolaryngol; 2018 Feb 01; 275(2):595-606. PubMed ID: 29224044 [Abstract] [Full Text] [Related]
18. Radiotherapy for solitary extramedullary plasmacytoma in the head-and-neck region: A dose greater than 45 Gy to the target volume improves the local control. Tournier-Rangeard L, Lapeyre M, Graff-Caillaud P, Mege A, Dolivet G, Toussaint B, Charra-Brunaud C, Hoffstetter S, Marchal C, Peiffert D. Int J Radiat Oncol Biol Phys; 2006 Mar 15; 64(4):1013-7. PubMed ID: 16343803 [Abstract] [Full Text] [Related]
19. Radiation-induced osteosarcomas in the pediatric population. Koshy M, Paulino AC, Mai WY, Teh BS. Int J Radiat Oncol Biol Phys; 2005 Nov 15; 63(4):1169-74. PubMed ID: 16054775 [Abstract] [Full Text] [Related]
20. Prognostic factors in patients with recurrent head and neck cancer treated with reirradiation. Krstevska V, Tolevska C, Zafirova-Ivanova B, Stojkovski I, Crvenkova S. J BUON; 2008 Nov 15; 13(3):369-76. PubMed ID: 18979552 [Abstract] [Full Text] [Related] Page: [Next] [New Search]